SSI Strategy Acquires NDA Group AB
August 15, 2023
SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.
- Buyers
- SSI Strategy
- Targets
- NDA Group AB
- Platforms
- SSI Strategy
- Industry
- Healthcare Services
- Location
- Sweden
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Clinigen Acquires SSI Strategy
November 21, 2025
Healthcare Services
Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.
-
SSI Strategy Acquires Fiore Healthcare Advisors
June 29, 2021
Healthcare Services
SSI Strategy, a life sciences consultancy backed by Amulet Capital Partners, has acquired Fiore Healthcare Advisors, a Boston-based pharmacovigilance and clinical research consultancy. The acquisition adds Safety Physicians and clinical research experts to SSI, expanding the company's drug safety, pharmacovigilance and clinical research capabilities for early- and mid-stage biopharma clients.
-
The Planet Group Acquires NDA Partners
November 3, 2020
Healthcare Services
The Planet Group, a Chicago-based provider of outsourced human capital and consulting solutions and a portfolio company of MidOcean Partners, agreed to acquire NDA Partners, a life sciences management consulting and contract development organization. The acquisition expands Planet's life sciences consulting and regulatory capabilities to better serve pharmaceutical, biotechnology and medical device clients; NDA Partners will remain led by CEO Earle Martin.
-
Amulet Capital Partners Makes Growth Investment in SSI Strategy
December 21, 2020
Healthcare Services
Amulet Capital Partners (a healthcare-focused private equity firm) made a growth equity investment in SSI Strategy Holdings LLC, a Parsippany, New Jersey-based life sciences consulting firm, to accelerate the company’s growth and expand strategic services including a new Gene Therapy Accelerator. The capital will fund team expansion, adjacent service lines and potential tuck-in acquisitions; Simon Kennedy joined SSI Strategy's board in conjunction with the investment.
-
InductiveHealth Acquires SSDataInfo
January 15, 2026
Healthcare Services
InductiveHealth has acquired SSDataInfo (SSDI) to strengthen its disease surveillance and public health technology offerings, combining SSDI's NEDSS Base System (NBS) expertise with InductiveHealth's cloud hosting, integrations, and data-quality capabilities. The deal expands hosting, interoperability, electronic onboarding, and ongoing support options for federal, state, tribal, territorial, and local public health agencies; together the companies serve more than 40 public health departments and agencies across the United States.
-
SAI MedPartners Acquires The Dunn Group
December 4, 2025
Healthcare Services
SAI MedPartners, a Northlane Capital Partners-backed healthcare consultancy, has acquired The Dunn Group, a Totowa, New Jersey-based competitive intelligence firm focused on pharmaceuticals, biotechnology, and medical devices. The acquisition expands SAI's competitive intelligence capabilities and deepens its life sciences market research and analytics offerings.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.